S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PHAT Phathom Pharmaceuticals Inc

5.67

0.00 (0.00%)

Pre Market

Last Updated: 22:13:42

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Phathom Pharmaceuticals (NASDAQ:PHAT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Phathom Pharmaceuticals Charts.

Phathom Pharmaceuticals (NASDAQ:PHAT)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Phathom Pharmaceuticals Charts.

Phathom Pharmaceuticals Inc News

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
Thursday 30 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
Thursday 12 December 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (4 months ago) • Edgar (US Regulatory)

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
Friday 8 November 2024 (4 months ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 5 November 2024 (4 months ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024
Monday 28 October 2024 (4 months ago) • GlobeNewswire Inc.

More Phathom Pharmaceuticals Inc News Articles

Invesco QQQ Trust Series 1

Gold vs US Dollar

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions